Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy

被引:0
|
作者
Oh, H. -J. [1 ,2 ]
Park, C. -K. [1 ,2 ]
Kim, Y. -C. [1 ,2 ]
Kim, Y. -H. [1 ,2 ]
Ahn, S. -J. [1 ,2 ]
Jeong, W. G. [1 ,2 ]
Lee, J. Y. [1 ,2 ]
Lee, J. C. [3 ]
Choi, C. M. [3 ]
Ji, W. [3 ]
Song, S. Y. [3 ]
Choi, J. [3 ,4 ]
Lee, S. Y. [4 ,5 ]
Kim, H. [4 ]
Lee, S. Y. [4 ,5 ]
Park, J. [5 ]
Yoon, S. H. [6 ]
Joo, J. H. [6 ]
Oh, I. -J. [1 ,2 ]
机构
[1] Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
[2] Hwasun Hosp, Jeonnam, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea
[4] Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea
[5] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[6] Pusan Natl Univ, Sch Med, Yangsan Hosp, Gyeongnam, South Korea
关键词
real-world data; chemoradiotherapy; durvalumab;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.28-12
引用
收藏
页码:S294 / S295
页数:2
相关论文
共 50 条
  • [41] PET for Prognostic Assessment in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Yilmaz, Ufuk
    Asuk, Zehra
    Koparal, Hakan
    Ozbilek, Engin
    Korkmaz, Esra
    Yalcin, Burcu
    Yilmaz, Hasan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S690 - S690
  • [42] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [43] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [44] Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancer
    Murata, Saori
    Horinouchi, Hidehito
    Morishita, Momoko
    Kaku, Sawako
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Yamamoto, Noboru
    Okuma, Kae
    Kusumoto, Masahiko
    Ohe, Yuichiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1396 - S1396
  • [45] Outcomes of patients with unresectable stage III non-small cell lung cancer treated with durvalumab and subsequent therapies after disease progression.
    Dickson, Franco Adjei-Baffour
    Raez, Luis E.
    Dumais, Katerine
    Powery, Herman W.
    Walker, Damaal
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] REAL-WORLD OUTCOMES OF CHEMORADIATION AND CONSOLIDATIVE DURVALUMAB IN UNRESECTABLE STAGE III NON-SMALL-CELL LUNG CANCER - A SYSTEMATIC REVIEW
    Hu, Hsin-pei
    Walker-Dilks, Cindy
    Swaminath, Anand
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S72 - S72
  • [47] Real-World Outcomes of Chemoradiation and Consolidative Durvalumab in Unresectable Stage III Non-Small-Cell Lung Cancer - A Systematic Review
    Hu, H. P.
    Walker, C.
    Swaminath, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E438 - E438
  • [48] Consolidation Treatment of Durvalumab After Chemoradiation in the Real World Patients of Stage Three Unresectable Non-Small Cell Lung Cancer: The Preliminary Result
    Ju, J.
    Huang, A.
    Wang, C.
    Chang, W.
    Kuo, C.
    Yang, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [49] Durvalumab Consolidation Following Chemoradiation for Unresectable Non-Small Cell Lung Cancer: A "Real-World" Experience.
    Griffiths, C.
    Menon, S.
    Thompson, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S366 - S367
  • [50] Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study
    Park, Ji Eun
    Hong, Kyung Soo
    Choi, Sun Ha
    Lee, Shin Yup
    Shin, Kyeong-Cheol
    Jang, Jong Geol
    Kwon, Yong Shik
    Park, Sun Hyo
    Choi, Keum-Ju
    Jung, Chi Young
    Eom, Jung Seop
    Kim, Saerom
    Seol, Hee Yun
    Kim, Jehun
    Kim, Insu
    Park, Jin Han
    Kim, Tae Hoon
    Ahn, June Hong
    CLINICAL LUNG CANCER, 2024, 25 (04) : 354 - 364